Related Experiment Video
Updated: Mar 12, 2026

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
[Ageing and Alzheimer disease - system dynamics model prediction]
This study models future Alzheimer's disease (AD) patient numbers and financial costs in the EU, driven by an aging population. The system dynamics model predicts a significant impact on the economy.
Area of Science:
- Gerontology and Public Health
- Health Economics
- Computational Modeling
Background:
- Alzheimer's disease (AD) is the most prevalent form of dementia, strongly linked to aging populations.
- The European Union faces demographic shifts with increasing life expectancy and low birth rates, exacerbating the aging population.
- Predictive modeling is crucial for understanding the future burden of AD and its economic consequences.
Purpose of the Study:
- To develop and present a system dynamics model for predicting the number of Alzheimer's disease patients in the EU.
- To estimate the associated financial impacts and economic burden of Alzheimer's disease in the future EU.
- To integrate a financial submodel for cost estimation based on existing studies.
Main Methods:
- Application of a system dynamics modeling approach.
- Development of a dynamic model simulating the EU population and Alzheimer's disease patient prevalence.
- Integration of a financial submodel to estimate patient costs using data from three cost studies.
Main Results:
- The system dynamics model provides future projections for Alzheimer's disease patient numbers within the EU.
- The financial submodel estimates the economic costs associated with the predicted increase in Alzheimer's disease patients.
- The study highlights the significant economic implications of an aging population on healthcare systems due to Alzheimer's disease.
Conclusions:
- System dynamics modeling is an effective tool for predicting the future prevalence of Alzheimer's disease and its economic impact.
- The aging EU population presents a substantial challenge, necessitating proactive planning for Alzheimer's disease care and associated costs.
- The model provides valuable insights for policymakers and healthcare planners to address the growing burden of Alzheimer's disease.
More Related Videos
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer's Disease: Treatment
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Additive and Proportional Drug Effect Model